Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **tear film and mucus layer of the ocular surface** are a multi-layered structure essential for eye health and vision. The tear film comprises aqueous, mucous, and lipid layers; the **mucus layer**, rich in mucins (high-molecular weight glycoproteins), stabilizes the tear film, keeps the surface hydrated, provides lubrication, and protects against pathogens and mechanical insults[1][2][3][4]. Goblet cells in the conjunctiva secrete the principal gel-forming mucin, *MUC5AC*, which is vital for maintaining ocular surface moisture and immune homeostasis[3][1]. Dysfunction or deficiency of the mucins is linked with dry eye and other ocular surface disorders[1][2][3]. The term "Ocular surface tear film and mucus layer" should be refined to a more molecularly specific entity (such as "Mucins of the ocular surface" or "MUC5AC") for accurate bioinformatics or therapeutic targeting purposes.
Enhancement of mucin secretion or protection Immunomodulation (by increasing goblet cell and mucin function)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tear film mucin of the ocular surface.